- Line-Up Includes Late-Breaking Abstract of BLOSSOM Phase 3 Trial Results and Physician Symposium with Spotlight on Lorcaserin's Mechanism of Action -
Oct. 12, 2009 (PR Newswire) --
SAN DIEGO, Oct. 12, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that lorcaserin will be featured in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC.
The line-up includes a late-breaking abstract oral presentation of results from BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management), a Phase 3 trial for which Arena reported positive, highly significant top-line results in September. Arena will also present new data analyses from lorcaserin's successful Phase 3 pivotal program in oral and poster sessions. In an independent clinical symposium, expert academic scientists and physicians will spotlight the 5HT-2C mechanism for weight management.
The positive results from our Phase 3 pivotal program highlight lorcaserin's potential to provide physicians with a treatment option that combines three important attributes - efficacy, safety and tolerability
"- critical to broad applicability in the majority of their patients to help manage weight and improve cardiometabolic health," stated William R. Shanahan, M.D., Arena's Vice President and Chief Medical Officer. "The breadth of presentations featuring lorcaserin at The Obesity Society's annual scientific meeting speaks to the strong interest physicians have in this drug candidate."
Obesity 2009: Presentation Schedule
Saturday, October 24, 2009
-- Pre-Conference Session: Pharmacotherapy Update
Time: 1:00 - 3:45 p.m. Eastern Time (ET)
Chairs: Ken Fujioka, M.D., Louis J. Aronne, M.D., and Richard
Pratley, M.D.
Presenter: Christen M. Anderson, M.D., Ph.D.
Sunday, October 25, 2009
-- Poster Session
Time: on display 1:00 - 7:00 p.m. ET; presenters will be available
to address questions from 1:00 - 2:00 p.m. and 6:30 - 7:30 p.m. ET
Presenters: William R. Shanahan, M.D., Christen M. Anderson, M.D.,
Ph.D., and Meredith Fidler, Ph.D.
-- Oral Abstract Presentation: Clinical Studies, Pharmacotherapy
Time: 6:00 - 6:15 p.m. ET
Presenter: Steven Smith, M.D.
Monday, October 26, 2009
-- Related Symposium: Spotlight on 5HT-2C
Time: 8:30 - 10:00 a.m. ET
Chairs: Jonathan Purnell, Ph.D., and Robert Berkowitz, M.D.
Speakers: Laurence Tecott, M.D., Ph.D.: Neuroscience of 5HT-2C;
Steven Smith, M.D.: Lorcaserin - Clinical Results; Neil Weissman,
M.D., F.A.C.C.: A Primer of Valvulopathy in Obesity
Tuesday, October 27, 2009
-- Oral Abstract Presentation: Late-Breaking Clinical Trial Symposium
Time: 10:40 - 11:00 a.m.
